Log In
Print
BCIQ
Print
Print this Print this
 

Lexaptepid pegol (NOX-H94)

  Manage Alerts
Collapse Summary General Information
Company Noxxon Pharma AG
DescriptionL-aptamer hepcidin inhibitor
Molecular Target Hepcidin
Mechanism of ActionHepcidin inhibitor
Therapeutic ModalityNucleic acid: Aptamer
Latest Stage of DevelopmentPhase II
Standard IndicationAnemia
Indication DetailsTreat anemia; Treat anemia in erythropoietin (EPO)-hyporesponsive dialysis patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today